分离因子突变对克隆性血液形成和髓状新生体进展的影响
Takuya Izumi-Tamura1, Asuka Kawachi1, Akihide Yoshimi1
1Division of Cancer RNA Research, National Cancer Center Research Institute, 104-0045 Tokyo, Japan.
Frontiers in bioscience (Landmark edition)
|November 6, 2025
概括
拼接因子突变加速克隆性血液形成 (CH) 扩张,增加白血病和心脏病的风险. 这些突变与其他遗传变化一起驱动疾病,突出潜在的治疗点.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 克隆性血液形成 (CH) 涉及突变的干细胞,增加了血液癌症和心血管疾病的风险.
- 分离因子 (SF) 突变是CH扩张和白血病发生的关键驱动因素.
研究的目的:
- 审查SF突变在CH进展中的作用.
- 探索SF突变与其他突变 (例如,DNMT3A,TET2,IDH2) 的相互作用,以及它们对造血元恒温的影响.
主要方法:
- 对CH克隆的流行病学研究的审查.
- 对研究SF突变效应的小鼠模型的分析.
- 检查SF突变与表观遗传突变和外部因素的相互作用.
主要成果:
- 与其他CH类型相比,SF突变CH表现出加速的克隆扩张.
- 当SF突变与像IDH2和TET2.2这样的表观遗传突变同时发生时,会增强疾病表型.
- SF突变通过协同相互作用促进CH扩张和恶性瘤.
结论:
- 在CH进展和白血病发生过程中,SF突变至关重要,通常与其他突变结合.
- 正在开发调节RNA拼接的向疗法,以预防CH驱动型白血病.
- 了解突变结合体机制可以改善CH检测,风险评估和治疗.
相关概念视频
RNA Splicing
60.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.3K
Alternative RNA Splicing
24.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.6K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Chromatin Structure Regulates pre-mRNA Processing
8.1K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
8.1K


